Brief: Fusion Pharmaceuticals Strengthens Actinium Supply With Onsite Isotope Production Through Expanded Bwxt Medical Collaboration
Nov 16 (Reuters) - BWX Technologies Inc BWXT.N :
* FUSION PHARMACEUTICALS STRENGTHENS ACTINIUM SUPPLY WITH
ONSITE
ISOTOPE PRODUCTION THROUGH EXPANDED BWXT MEDICAL COLLABORATION
* FUSION PHARMACEUTICALS INC: COLLABORATION ENABLES FUSION
TO
PRODUCE HIGH PURITY ACTINIUM-225 AT COMPANY'S GMP MANUFACTURING
FACILITY
Source text for Eikon: ID:nPn6GwRVra
Further company coverage: BWXT.N
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BWX Technologies
See all newsBrief: BWX Technologies In Talks With Polish Gov And Industry To Deploy Microreactors And SMRS
Norway wealth fund should invest in top arms makers, commission says in ethics overhaul (updated)
Norway should allow wealth fund to invest in major arms makers, commission says
Norway's wealth fund set to overhaul ethical rules after US scrutiny
US RESEARCH ROUNDUP-Essex Property Trust, Qualys, Vulcan Materials